GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 165 filers reported holding GOSSAMER BIO INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $446,460 | -76.3% | 536,095 | -65.8% | 0.00% | -80.0% |
Q2 2023 | $1,883,242 | -20.3% | 1,569,368 | -16.3% | 0.01% | -28.6% |
Q1 2023 | $2,362,902 | -25.6% | 1,875,319 | +28.2% | 0.01% | -30.0% |
Q4 2022 | $3,174,970 | -71.4% | 1,463,120 | +58.1% | 0.01% | -73.7% |
Q3 2022 | $11,090,000 | +439.7% | 925,727 | +277.0% | 0.04% | +442.9% |
Q2 2022 | $2,055,000 | -47.3% | 245,560 | -45.3% | 0.01% | -41.7% |
Q1 2022 | $3,898,000 | +3.7% | 449,057 | +35.2% | 0.01% | +50.0% |
Q4 2021 | $3,758,000 | +57.9% | 332,251 | +75.5% | 0.01% | +60.0% |
Q3 2021 | $2,380,000 | -38.7% | 189,360 | -60.4% | 0.01% | -44.4% |
Q2 2021 | $3,882,000 | -39.9% | 478,060 | -31.5% | 0.01% | -47.1% |
Q1 2021 | $6,457,000 | +295.4% | 698,075 | +313.4% | 0.02% | +240.0% |
Q4 2020 | $1,633,000 | -63.2% | 168,855 | -52.8% | 0.01% | -68.8% |
Q3 2020 | $4,437,000 | +16.5% | 357,563 | +22.0% | 0.02% | -15.8% |
Q2 2020 | $3,809,000 | +1265.2% | 293,019 | +966.8% | 0.02% | +850.0% |
Q1 2020 | $279,000 | – | 27,466 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |